Resultados: 17

Restenosis, procedural success and long-term outcomes after percutaneous mitral balloon commissurotomy in rheumatic mitral disease: large single-center experience

J. Am. Coll. Cardiol; 84 (18 Suppl. B), 2024
BACKGROUND Percutaneous mitral balloon commissurotomy (PMBC) remains the fust choice of treatment in appropriate candidates with mitral valve (MV) stenosis (MS) and ideal anatomy. The objective of this study was to identify the risk factors of MV restenosis in a large cohort of patients submitted to PMBC...

Independent clinical and echocardiographic predictors of restenosis after percutaneous mitral balloon commissurotomy in a large, consecutive cohort followed for 24 years

J. invasive cardiol; 35 (3), 2023
OBJECTIVES: to enlighten preprocedural risk factors of mitral valve restenosis in a large, single-center cohort of patients submitted to percutaneous mitral balloon commissurotomy (PMBC) for the treatment of mitral stenosis (MS) secondary to rheumatic heart disease. METHODS: this is a database analysis o...

Independent clinical and echocardiographic predictors of restenosis after percutaneous mitral balloon commissurotomy followed for 24 years

Arq. bras. cardiol; 119 (4 supl.1), 2022
BACKGROUND: Mitral valve stenosis (MVS) is one of the most common structural heart diseases in developing countries, primarily due to rheumatic disease. Percutaneous mitral balloon valvuloplasty (PMBV) has been, since its introduction in 1984, the preferred option of treatment for such disease. However, ...

Long-term follow-up in patients with rheumatic mitral stenosis and severe pulmonary artery hypertension submitted to percutaneous mitral balloon commissurotomy

Arq. bras. cardiol; 119 (4 supl.1), 2022
BACKGROUND: Percutaneous balloon mitral commissurotomy (PMBC) is an attractive therapeutic approach in patients with mitral stenosis. The aim of this study was to assess the immediate and long-term clinical, echocardiographic and haemodynamic outcomes of PMBC in patients with severe pulmonary hypertensio...

Immediate and long-term predictor score of success after percutaneous mitral balloon commissurotomy

Arq. bras. cardiol; 119 (4 supl.1), 2022
BACKGROUND: Percutaneous mitral balloon commissurotomy (PMBC) remains the preferred treatment for patients with severe symptomatic rheumatic mitral stenosis (MS) and suitable anatomy. The objective of this study was to propose a new score for the prediction of immediate and late success. METHODS. This is...

Preditores independentes de reestenose da valva mitral após valvoplastia mitral percutânea por balão em uma grande coorte consecutiva com seguimento clínico por mais de duas décadas
Independent predictors of mitral valve restenosis after percutaneous balloon mitral valvuloplasty in a large consecutive cohort with clinical follow-up for more than two decades

J. Transcatheter Interv; 30 (supl.1), 2022
INTRODUÇÃO: A valvoplastia mitral percutânea com balão (VMPB), sempre que tecnicamente viável, é a opção de tratamento preferencial para a estenose mitral, particularmente aquelas secundárias à doença cardíaca reumática. No entanto, a reestenose valvar mitral pode se desenvolver em um númer...

Seguimento a longo prazo de valvuloplastia mitral percutânea em pacientes com estenose reumática mitral e hipertensão arterial pulmonar grave
Long-term follow-up of percutaneous mitral valvuloplasty in patients with rheumatic mitral stenosis and severe pulmonary arterial hypertension

J. Transcatheter Interv; 30 (supl.1), 2022
INTRODUÇÃO: A hipertensão arterial pulmonar pode ser um fator de complicação em pacientes com estenose valvar reumática e que serão submetidos a valvuloplastia mitral percutânea por balão (VMPB), sendo esta uma abordagem terapêutica atraente em pacientes com estenose mitral de origem reumática...

“Valve-in-Valve” mitral em paciente jovem e clinicamente instável
Mitral “Valve-in-Valve” in a young clinically unstable patient

INTRODUÇÃO: As biopróteses cirúrgicas tem durabilidade aproximada de 12 a 20 anos, e a ocorrência de degeneração protética pode exigir novas intervenções. A cirurgia de retroca valvar está associada à maior risco, principalmente em pacientes com insuficiência cardíaca (IC). Neste cenário, ...

Independent clinical and echocardiographic predictors of restenosis after percutaneous mitral balloon commissurotomy followed for 24 years

Arq. bras. cardiol; 117 (5 supl. 1), 2021
INTRODUCTION: Mitral valve stenosis (MVS) is one of the most common structural heart diseases in developing countries, primarily due to rheumatic disease. Percutaneous mitral balloon valvuloplasty (PMBV) has been, since its introduction in 1984, the preferred option of treatment for such disease. However...

Long-term follow-up in patients with rheumatic mitral stenosis and severe pulmonary artery hypertension submitted to percutaneous mitral balloon commissurotomy

Arq. bras. cardiol; 117 (5 supl. 1), 2021
INTRODUCTION: Percutaneous balloon mitral commissurotomy (PMBC) is an attractive therapeutic approach in patients with mitral stenosis. OBJECTIVE: The aim of this study was to assess the immediate and long-term clinical, echocardiographic and haemodynamic outcomes of PMBC in patients with severe pulmonar...